remdesivir

News

UK okays early access to Gilead's remdesivir in seriously il...

The UK’s drugs regulator has said that there is enough evidence to support the use of Gilead’s COVID-19 drug remdesivir under its Early Access to Medicines Scheme (EAMS).

News

Study sets benchmark for cost of repurposed coronavirus drug...

Scientists have warned that the main drugs being repurposed for COVID-19 could end up being too expensive for many people around the world – unless drugmakers are prepared to s

News

Japan approves Gilead's COVID-19 drug remdesivir

Japan’s regulator has quickly approved Gilead’s remdesivir for patients with severe COVID-19, after the FDA allowed its use as an emergency treatment for the disease earlier this month.

News

Gilead working with generics firms to boost global supply of...

Gilead has outlined plans to work with generics firms to rapidly increase production of its COVID-19 drug remdesivir to meet global demand.

News

First doses of Gilead's COVID-19 drug remdesivir to arrive a...

The first doses of Gilead’s COVID-19 drug remdesivir are set to arrive in US hospitals this week after the FDA said the medicine can be used to fight the coronavirus pandemic.

News

Covid-19 drug will be 'affordable' says Gilead, as it plans ...

Gilead has outlined its plans to develop and ramp up production of its remdesivir COVID-19 drug, with CEO Daniel O’Day pledging to ensure it is affordable after phase 3 results showed it cu

UK okays early access to Gilead's remdesivir in seriously il...

Study sets benchmark for cost of repurposed coronavirus drug...

Japan approves Gilead's COVID-19 drug remdesivir

Gilead working with generics firms to boost global supply of...

First doses of Gilead's COVID-19 drug remdesivir to arrive a...

Covid-19 drug will be 'affordable' says Gilead, as it plans ...

GSK pursues $10.6bn takeover of cancer biotech Nuvalent

Discover a new era of healthcare panel engagement: Grounded ...

remdesivir

Editor's Picks